Could Weight-Loss Drugs Curb Addiction? Your ...

In this episode of Science Quickly, we start with a quick update on the Ebola outbreak surging in parts of Africa. Host Rachel Feltman is then joined by Scientific American’s senior desk editor for life science Andrea Thompson to discuss what rising temperatures mean for the FIFA ...  Show more

In this episode of Science Quickly, one of SciAm’s Young American Scientists, biologist Jaye Gardiner, explores how common viral infections may raise cancer risk—not just through genetic mutations but by reshaping the body’s “extracellular matrix” of molecules that support cells ...  Show more

Yes, drugs like Ozempic, Wegovy, and Mounjaro can help people lose weight, but at what cost? Dr. Sanjay Gupta explores why these drugs may not be the right fit for everyone. Learn more about your ad choices. Visit podcastchoices.com/adchoices 

A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ...  Show more

New drugs like Wegovy, Ozempic and Mounjaro are billed as a revolutionary new approach for losing weight. But are these actually miracle drugs? Dr. Sanjay Gupta turns to Yale School of Medicine assistant professor Dr. Jorge Moreno to explain the science behind these medications – ...  Show more

Barely a day goes by without more headlines around new weight-loss drugs, from the issue of global shortages, to investigations into suicide risk, and debate over just how long people will need to be on them. But in this episode of Inside Health we’re going to look at something s ...  Show more